Acute Myeloid Leukemia Cells Generate Leukemic Endothelial Cells with Leukemogenic Potential: Blood Vessels As Sanctuaries for Leukemia Relapse
Christopher R. Cogle(University of Florida), William H. Fleming(Oregon Health & Science University), Amy Meacham(University of Florida), Qiuying Liu(Chinese PLA General Hospital), Azzah Al Masri(Oregon Health & Science University), Gerard J. Madlambayan(University of Rochester), Edward W. Scott(University of Florida), Devorah C. Goldman(Oregon Health & Science University), Jennifer Dunlap(Oregon Health & Science University), Tibor Kovacsovics(Hôpital Edouard Herriot), Ronald P. Leon(Oregon Health & Science University)
Cited by 1
Related Papers
Alginate hydrogels as synthetic extracellular matrix materials
|Biomaterials|1999|2.3k
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547
Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2018|268